Special Guest Op-Ed: What a decade of collaboration and shared effort reveals about the future of drug development.
Andy Lee
Advertisement
A founding member of TransCelerate BioPharma Inc. and a retired global clinical operations executive. During his career, he led worldwide clinical trial operations at Merck and held senior leadership roles at Sanofi, Genzyme, and Pfizer. He helped shape TransCelerate’s early strategy, governance, and project portfolio and served on its board as treasurer.
Articles by Andy Lee
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Appoints Belén Garijo as Chief Executive Officer
2
Former AstraZeneca Executive Charged with Several Offenses in China
3
Today’s China Crucible: What It Means for Pharma
4
FDA Approves Keytruda-Based Regimen for PD-L1–Positive Platinum-Resistant Ovarian Cancer
5